Stockreport

Interpace up 9% after hours on Cancer Genetics deal [Seeking Alpha]

CANCER GENETICS  (CGIX) 
Last cancer genetics earnings: 11/19 04:16 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cancergenetics.com
PDF Interpace Diagnostics (NASDAQ: IDXG ) has acquired Cancer Genetics' (NASDAQ: CGIX ) Biopharma Services business for ~$23.5M subject to adjustments. The busine [Read more]